Salehi B, Venditti A, Sharifi-Rad M, Krgiel D, Sharifi-Rad J, Durazzo A, et al
In laboratory settings, GHK-Cu may be used to investigate: All uses are limited to research settings only
The effect of glucagon-like peptide-1 receptor agonists on cardiac function and structure in patients with or without type 2 diabetes mellitus: An updated systematic review and meta-analysis
NFATc1-mediated expression of SLC7A11 drives sensitivity to TXNRD1 inhibitors in osteoclast precursors
Product Note: All products are shipped in lyophilized (powder) form and require reconstitution prior to research use
We also found a lower rate of initiation of treatment with anti-VEGF inhibitors, a class of agents commonly used to treat DR and DME that costs Medicare Part D nearly $1 billion per year